Evidence map›Paper›PMID 28558828›Full record

Trial reportBMC veterinary research2017

Eprinomectin pour-on (EPRINEX® Pour-on, Merial): efficacy against gastrointestinal and pulmonary nematodes and pharmacokinetics in sheep.

Dietmar Hamel, Antonio Bosco, Laura Rinaldi, Giuseppe Cringoli, Karl-Heinz Kaulfuß, Michael Kellermann, James Fischer, Hailun Wang, Katrin Kley, Sandra Mayr and 5 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMC veterinary research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.1field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 32 citations in OpenAlex.

  1. Journal of veterinary research · 2025
    Article
  2. Article
  3. Comparing ShortAnimals : an open access journal from MDPI · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 3 countries.

Dietmar HamelMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany. dietmar.hamel@merial.com.ORCID http://orcid.org/0000-0001-6594-6743
Antonio BoscoDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, Via della Veterinaria, 1, 80137, Naples, Italy.
Laura RinaldiDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, Via della Veterinaria, 1, 80137, Naples, Italy.
Giuseppe CringoliDepartment of Veterinary Medicine and Animal Production, University of Naples Federico II, Via della Veterinaria, 1, 80137, Naples, Italy.
Karl-Heinz KaulfußTierarztpraxis Hoffmann, Untere Schulstraße 8, 38875, Elbingerode, Germany.
Michael KellermannMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
James FischerMerial, Inc., North Brunswick Research Center, 631 Route 1 South, North Brunswick, NJ, 08902, USA.
Hailun WangMerial, Inc., 3239 Satellite Blvd., Duluth, GA, 30096-4640, USA.
Katrin KleyMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
Sandra MayrMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
Renate RauhMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
Martin VisserMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
Thea WiefelMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
Becky FankhauserMerial, Inc., 3239 Satellite Blvd., Duluth, GA, 30096-4640, USA.
Steffen RehbeinMerial GmbH, Kathrinenhof Research Center, Walchenseestr. 8-12, 83101, Rohrdorf, Germany.
University of Naples Federico II · ITBrunswick (United States) · USLohmann Tierzucht (Germany) · DEWalmart (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe anthelmintic efficacy of the 0.5% w/v topical formulation of eprinomectin (EPN), EPRINEX® Pour-on (Merial) when administered at 1 mg/kg body weight was evaluated in sheep in two dose confirmation laboratory studies and one multicenter field study. In addition, the pharmacokinetics of EPN when administered at that dosage to adult sheep was determined.

resultsIn the two dose confirmation studies, which included 10 sheep each, sheep treated with topical EPN had significantly (p < 0.05) fewer of the following nematodes than the untreated sheep with overall reduction of nematode counts by >99%: adult Dictyocaulus filaria, Haemonchus contortus, Teladorsagia circumcincta(pinnata/trifurcata), Trichostrongylus axei, T. colubriformis, T. vitrinus, Cooperia curticei, Nematodirus battus, Strongyloides papillosus, Chabertia ovina and Oesophagostomum venulosum, and inhibited fourth-stage Teladorsagia larvae. A total of 196 sheep harboring naturally acquired gastrointestinal nematode infections were included in the field efficacy study at two sites each in Germany (48 Merino x Ile de France lambs, 52 adult Merino females) and in Italy (adult male and female Bagnolese, Lacaune, Lacaune x Bagnolese, Bagnolese x Sarda sheep; 48 animals per site). Animals were blocked on pre-treatment body weight and within each block, one animal was randomly assigned to the control (untreated) group and three animals were randomly assigned to be treated with topical EPN. Examination of feces 14 days after treatment demonstrated that, relative to the controls, topical EPN-treated sheep had significantly (p < 0.0001) lower strongylid egg counts. Reduction was ≥97% at each site and 98.6% across all sites. Pharmacokinetics of EPN following single treatment with topical EPN were determined in eight ~4.5 year old female Merino cross sheep based on the analysis of plasma samples which were collected from two hours to 21 days following treatment. The main pharmacokinetic parameters were: C

conclusionThese studies demonstrated 0.5% w/v EPN administered topically at 1 mg/kg body weight to be highly efficacious against a broad range of ovine gastrointestinal nematodes and D. filaria lungworms and well tolerated by sheep of different ages, breeds, gender and physiological status.

Indexed as

AnimalsAntinematodal AgentsFemaleGastrointestinal DiseasesHelminthiasis, AnimalIvermectinLung Diseases, ParasiticMaleNematode InfectionsSheepSheep DiseasesAntinematodal AgentseprinomectinIvermectinEprinomectinGastrointestinal nematodesLungwormsPharmacokineticsSheepTopical

Identifiers

PMID28558828
PMCPMC5450133
OpenAlexW2620156354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.